Discovery of a novel, selective SIK3 inhibitor for the treatment of ulcerative colitis, Crohn’s disease and other autoimmune diseases Oct 6 Written By Evelien Micholt Presentation by F. Kolb on UEG Week 2025 October 6, Berlin Evelien Micholt
Discovery of a novel, selective SIK3 inhibitor for the treatment of ulcerative colitis, Crohn’s disease and other autoimmune diseases Oct 6 Written By Evelien Micholt Presentation by F. Kolb on UEG Week 2025 October 6, Berlin Evelien Micholt
